Jea Lee
Stock Analyst at Morgan Stanley
(1.17)
# 3,714
Out of 4,598 analysts
9
Total ratings
42.9%
Success rate
-4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jea Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4553 Towa Pharmaceutical Co., Ltd. | Upgraded: Buy | ¥5,600 | ¥3,910 | +43.22% | 1 | Jun 12, 2026 | |
| TYO: 4521 Kaken Pharmaceutical Co., Ltd. | Maintained: Buy | ¥5,600 → ¥5,500 | ¥3,820 | +43.98% | 4 | Sep 26, 2025 | |
| TYO: 4540 Tsumura & Co. | Maintained: Hold | ¥3,600 | ¥3,790 | -5.01% | 2 | Sep 26, 2025 | |
| TYO: 4516 Nippon Shinyaku Co., Ltd. | Maintained: Sell | ¥2,600 | ¥3,423 | -24.04% | 2 | Sep 26, 2025 |
Towa Pharmaceutical Co., Ltd.
Jun 12, 2026
Upgraded: Buy
Price Target: ¥5,600
Current: ¥3,910
Upside: +43.22%
Kaken Pharmaceutical Co., Ltd.
Sep 26, 2025
Maintained: Buy
Price Target: ¥5,600 → ¥5,500
Current: ¥3,820
Upside: +43.98%
Tsumura & Co.
Sep 26, 2025
Maintained: Hold
Price Target: ¥3,600
Current: ¥3,790
Upside: -5.01%
Nippon Shinyaku Co., Ltd.
Sep 26, 2025
Maintained: Sell
Price Target: ¥2,600
Current: ¥3,423
Upside: -24.04%